Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 587, doi. 10.1007/s40261-017-0519-y
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2017 AND VI 37 AND IP 7
Results: 12
1
2
Exposure-Safety Response Relationship for Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Data from Five Phase II and Six Phase III Studies.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 647, doi. 10.1007/s40261-017-0520-5
- By:
- Publication type:
- Article
3
Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 635, doi. 10.1007/s40261-017-0521-4
- By:
- Publication type:
- Article
4
Relationship Between the Expression of O-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response in Metastatic Pancreatic Adenocarcinoma Treated with FOLFIRINOX.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 669, doi. 10.1007/s40261-017-0522-3
- By:
- Publication type:
- Article
5
Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 625, doi. 10.1007/s40261-017-0523-2
- By:
- Publication type:
- Article
6
Oral Teicoplanin as an Alternative First-Line Regimen in Clostridium difficile Infection in Elderly Patients: A Case Series.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 699, doi. 10.1007/s40261-017-0524-1
- By:
- Publication type:
- Article
7
Evaluation of the Pharmacokinetics and Pharmacodynamics of Prasugrel in Japanese Elderly Subjects.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 679, doi. 10.1007/s40261-017-0525-0
- By:
- Publication type:
- Article
8
Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 687, doi. 10.1007/s40261-017-0526-z
- By:
- Publication type:
- Article
9
Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 705, doi. 10.1007/s40261-017-0534-z
- By:
- Publication type:
- Article
10
Response to Sharma et al.: Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 709, doi. 10.1007/s40261-017-0535-y
- By:
- Publication type:
- Article
11
The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 659, doi. 10.1007/s40261-017-0513-4
- By:
- Publication type:
- Article
12
Erratum to: Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future.
- Published in:
- Clinical Drug Investigation, 2017, v. 37, n. 7, p. 711, doi. 10.1007/s40261-017-0544-x
- By:
- Publication type:
- Article